Clinical Trials Logo

Clinical Trial Summary

Differences in efficacy and safety between new oral anticoagulants (NOAC) and vitamin K antagonist (VKA) in real practice remain uncertain.

The few existing ambulatory studies did not answer all NOAC specific issues, such as prescription habits and motives, patients characteristics, biological monitoring, as well as the occurrence of major and minor thromboembolic events, especially in France where warfarin is less frequently prescribed.

Therefore, in order to describe clinical and follow up characteristics of patients receiving oral anticoagulants, the investigators will set up a national prospective cohort to compare the occurrence of thromboembolic events between VKA and NOAC in primary care.


Clinical Trial Description

The method includes the use of a national prospective observational cohort, involving 444 general practitioners From april to december 2014, health data of any adult patient consulting a general practitioner and receiving an oral anticoagulant treatment has been entered in a database. Each patient received an information for agreement to participate to the study (agreement for stastical analysis of their health data during one year follow up).

In March 2015, half of those patients will be chosen (stratification), using a matched stratification process, and will be followed up over one year. Every three months, data regarding the occurrence of therapeutics changes, episodes of excessive bleeding, and thromboembolic events will be collected by general practitioners.

The data will be analysed by: - describing the characteristics of patients receiving oral anticoagulant treatment; - describing the changes of medications over the year ; - comparing the occurrence of episodes of excessive bleeding ; - comparing the occurrence of thromboembolic events in patients using VKA versus patients using NOAC. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02376777
Study type Observational
Source CNGE IRMG Association
Contact
Status Completed
Phase N/A
Start date April 2014
Completion date June 2017

See also
  Status Clinical Trial Phase
Recruiting NCT04304651 - Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism N/A
Completed NCT00216866 - The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis Phase 2
Recruiting NCT05907564 - Aventus Thrombectomy System Pulmonary Embolism Clinical Study N/A
Completed NCT05128591 - A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091 Phase 1
Completed NCT00670540 - Epidemiology of Thromboembolism Disease: A Cohort Study N/A
Recruiting NCT04263038 - Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism Phase 4
Recruiting NCT04388657 - COVID-19, bLOod Coagulation and Thrombosis
Completed NCT04439383 - Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
Completed NCT01897103 - Platelet Activity in Vascular Surgery for Thrombosis and Bleeding N/A
Recruiting NCT04657120 - Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy N/A
Completed NCT02720328 - Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants Phase 4
Completed NCT01203098 - A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty Phase 2
Completed NCT00830570 - The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings N/A
Recruiting NCT05568966 - Collection of Blood Samples for New Diagnostic Devices 2 N/A
Not yet recruiting NCT06209892 - Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis N/A
Completed NCT01086215 - Registry of AngioJet Use in the Peripheral Vascular System N/A
Completed NCT02996851 - Traumatic Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs N/A
Completed NCT00119457 - Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) Phase 2
Recruiting NCT05853796 - Observational Dutch Young Symptomatic StrokE studY - nEXT
Terminated NCT02610608 - Medical Assistance for the Procreation and Risk of Thrombosis.